Keyphrases
In Vitro Fertilization
97%
Gonadotropin-releasing Hormone
52%
Controlled Ovarian Stimulation
40%
IVF Cycles
32%
Pregnancy Rate
30%
In Vitro Fertilization-embryo Transfer (IVF-ET)
27%
Follicle-stimulating Hormone
26%
Cycle Outcomes
26%
Recurrent Implantation Failure
25%
Embryo Transfer
24%
In Vitro Fertilization Cycle
22%
Gonadotropins
22%
Short Protocol
22%
Superovulation
20%
Ovarian Response
20%
Treatment Cycle
18%
High-quality Embryo
18%
Oocyte number
18%
Pregnancy Outcome
16%
Assisted Hatching
16%
Spermatozoa
16%
Fetal Ovary
16%
Semen Quality
16%
Ovarian Hyperstimulation Syndrome
15%
Estradiol Level
15%
Infertility
15%
Ovum pick-up
15%
Menotropins
14%
Intracytoplasmic Sperm Injection
14%
Ovulation Induction
14%
Oral Contraceptives
13%
Proembryo
13%
Human Menopausal Gonadotropin
12%
GnRH Antagonist Protocol
12%
In Vitro Embryo Production
12%
Low Fertilization Rate
12%
Fertilization Rate
12%
Sperm Concentration
11%
Fertilization Program
11%
Gonadotropin-releasing Hormone Antagonist Protocol
11%
Human Chorionic Gonadotropin Injection
11%
Patient Selection
10%
Spermatogenesis
10%
Progesterone Level
10%
Cycle Parameters
10%
Serum Estradiol
10%
Poor Ovarian Response
10%
Nafarelin
10%
Infertile Patients
9%
Buserelin
9%
Medicine and Dentistry
In Vitro Fertilisation
100%
Oocyte
51%
In Vitro
38%
Embryo Transfer
30%
Fertilization
26%
Diethylstilbestrol
23%
Controlled Ovarian Hyperstimulation
23%
Gonadorelin Derivative
22%
Intracytoplasmic Sperm Injection
21%
Human Menopausal Gonadotropin
20%
Follitropin
18%
Gonadotropin
18%
Oral Contraceptive Agent
16%
Hatching
16%
Azoospermia
16%
Follicle
15%
Semen Analysis
14%
Ovulation Induction
14%
Pregnancy Rate
13%
Chorionic Gonadotropin
13%
Embryo Quality
12%
Lymphocyte
12%
Ovarian Hyperstimulation Syndrome
11%
Superovulation
11%
Spermiogenesis
10%
Gonadotropin-Releasing Hormone
10%
Immune System
10%
Progesterone
10%
Prevalence
10%
Low Drug Dose
10%
Nafarelin
10%
Testes
8%
Blood Flow
8%
Early Cancer
8%
Aromatase Inhibitor
8%
Placenta Development
8%
Endometrium Carcinoma
8%
Aryldialkylphosphatase 1
8%
Malignant Neoplasm
8%
Clinical Trial
8%
Healthy Eating
8%
Oocyte Maturation
8%
Releasing Factor
8%
Orchiectomy
8%
Buserelin
8%
Luteinizing Hormone
8%
Hyperactivity
8%
Dietary Pattern
8%
Newborn Assessment
8%
Testis Cancer
8%
